We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
251
Regeneron Pharmaceuticals
REGN
$76.6B
$3.01M 0.07%
7,477
+80
+1% +$32.1K
GVI icon
252
iShares Intermediate Government/Credit Bond ETF
GVI
$3.77B
$2.99M 0.07%
26,468
-5,722
-18% -$646K
XPRO icon
253
Expro Ltd
XPRO
$1.77B
$2.94M 0.07%
37,736
-928
-2% -$71.6K
TDAY
254
USA Today Co
TDAY
$1.26B
$2.93M 0.07%
189,130
+158,250
+512% +$2.72M
WM icon
255
Waste Management
WM
$90.6B
$2.91M 0.07%
45,676
+10,150
+29% +$664K
ACM icon
256
Aecom
ACM
$9.34B
$2.87M 0.07%
96,502
+2,409
+3% +$77.6K
FNHC
257
DELISTED
FedNat Holding Company Common Stock
FNHC
$2.85M 0.07%
152,450
+28,510
+23% +$541K
AKS
258
DELISTED
AK Steel Holding Corp
AKS
$2.81M 0.07%
+581,360
New +$2.95M
ARMK icon
259
Aramark
ARMK
$15B
$2.81M 0.07%
102,220
+3,033
+3% +$80.1K
VCSH icon
260
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.78M 0.07%
34,533
+1,969
+6% +$159K
SYF icon
261
Synchrony
SYF
$24.8B
$2.75M 0.07%
98,106
+2,469
+3% +$67.8K
PIPR icon
262
Piper Sandler
PIPR
$5.1B
$2.74M 0.07%
+226,760
New +$2.47M
INDB icon
263
Independent Bank
INDB
$3.98B
$2.71M 0.07%
50,115
-395
-0.8% -$20.1K
HEES
264
DELISTED
H&E Equipment Services
HEES
$2.7M 0.07%
161,245
-132,505
-45% -$2.27M
LMT icon
265
Lockheed Martin
LMT
$134B
$2.68M 0.07%
11,184
-4,044
-27% -$1.01M
CMS icon
266
CMS Energy
CMS
$22.7B
$2.65M 0.07%
63,125
-1,558
-2% -$68K
AVGO icon
267
Broadcom
AVGO
$1.85T
$2.65M 0.07%
153,470
-3,900
-2% -$65.2K
PKG icon
268
Packaging Corp of America
PKG
$21.9B
$2.54M 0.06%
31,209
+670
+2% +$51.2K
RAD
269
DELISTED
Rite Aid Corporation
RAD
$2.53M 0.06%
16,435
-41
-0.2% -$6.12K
ROST icon
270
Ross Stores
ROST
$80.7B
$2.48M 0.06%
38,541
-1,935
-5% -$119K
MUNI icon
271
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.05B
$2.42M 0.06%
44,056
+3,816
+9% +$210K
COP icon
272
ConocoPhillips
COP
$145B
$2.4M 0.06%
55,263
-4,353
-7% -$181K
AGN
273
DELISTED
Allergan plc
AGN
$2.35M 0.06%
10,225
-5,878
-37% -$1.44M
MINT icon
274
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$2.34M 0.06%
23,104
-1,452
-6% -$147K
JKHY icon
275
Jack Henry & Associates
JKHY
$10.9B
$2.33M 0.06%
27,284
+429
+2% +$37.6K

Similar funds

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.